BioSpace News Archive

Dr Carmen Escuriola-Ettingshausen and Dr Robert Sidonio are pleased to announce that MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) has been approved in the United States and Europe and is now recruiting participants.

Final analysis of the Phase 1/2 clinical study to be presented as a late-breaking virtual presentation at the ESMO World Congress on Gastrointestinal Cancer (WCGI) on July 1, 2020

Ascentage Pharma announced that the Phase II clinical study of the company’s novel inhibitor of apoptosis proteins antagonist APG-1387 in combination with entecavir for the treatment of patients with CHB has dosed its first patient in China.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that the healthcare investment bank Chardan has initiated analyst coverage of Sensorion.

Pougnier brings more than 30 years of global experience as a senior agtech executive to lead the next phase of growth

CAE announced that its CAE Air1™ ventilator has been certified by Health Canada.

Medscape announced the launch of the Medscape Salary Explorer, a new digital tool delivering up-to-date physician compensation data for virtually every zip code across the U. S.

Mandy Hale, DNP, MSN, MBA, RN, CNN, promoted to new clinical leadership role after 19 years of serving dialysis patients with DaVita

With novel drug development platform in place, the company deepens pharmaceutical industry expertise and connections

United Therapeutics Corporation announced that key data from the INCREASE study of Tyvaso® Inhalation Solution in patients suffering from World Health Organization Group 3 pulmonary hypertension associated with interstitial lung disease will be presented at a Breaking News Session hosted by the American Thoracic Society on June 24, 2020.